Document ID: ./input/supremecourt_opinions/opinions/12PDF/12-398_1B7D.pdf
Page Number: 21

18 

ASSOCIATION FOR MOLECULAR PATHOLOGY v.
 
MYRIAD GENETICS, INC.
 
Opinion of the Court 

limited to such applications.”  689 F. 3d, at 1349. 

Nor  do  we  consider  the  patentability  of  DNA  in  which 
the  order  of  the  naturally  occurring  nucleotides  has  been 
altered.  Scientific alteration of the genetic code presents a 
different  inquiry,  and  we  express  no  opinion  about  the 
application  of  §101  to  such  endeavors.  We  merely  hold
that genes and the information they encode are not patent 
eligible under §101 simply because they have been isolated
from the surrounding genetic material. 

* 

* 

* 

For  the  foregoing  reasons,  the  judgment  of  the  Federal 

Circuit is affirmed in part and reversed in part. 

It is so ordered.